Powered by: Motilal Oswal
2026-04-23 05:39:34 pm | Source: GEPL Capital Ltd
The index opened on a gap-down note and remained range-bound throughout the session by GEPL Capital Ltd
The index opened on a gap-down note and remained range-bound throughout the session by GEPL Capital Ltd

Market News:

* Speciality Medicines Ltd inks ~$2 mn (Rs.18.8 cr) global distribution deal, boosting reach and revenue visibility.

* J Kumar Infraprojects Limited secures Rs.2,487.65 crore worth of project orders in Mumbai.

* Cipla receives U.S. FDA approval for first AB Rated Generic of Ventolin HFA

Technical Summary:

The index opened on a gap-down note and remained range-bound throughout the session. On the daily timeframe, it settled near its 50 DEMA, indicating a lack of strong directional momentum. On the sectoral front, pharma and healthcare emerged as the top gainers, while auto and PSU banks underperformed during the day.

Levels to watch:

The Nifty has its crucial resistance 24350 (Pivot Level) and 24500 (Key Resistance). While support on the downside is placed at 24000 (Multiple Touches) and 23900 (Key Support).

What should short term traders expect?

The Index can LONG above 24250 for the potential target of 24350 AND 24400 the stop loss of 24180 level.

Technical Data Points

NIFTY SPOT: 24158.5 (-0.90%)

TRADING ZONE:

Resistance: 24350 (Pivot Level) and 24500 (Key Resistance)

Support: 24000 (Multiple Touches) and 23900 (Key Support).

STRATEGY: Bullish Till above 23900 (Key Support).

BANK NIFTY SPOT: 56314 (-1.42%)

TRADING ZONE:

Resistance: 57000 (Pivot Level) / 57800 (Key Resistance)

Support: 55700 (Pivot Level) / 55500 (Key Support)

STRATEGY: Bullish Till above 55500 (Key Support).

 

 

SEBI Registration number is INH000000081.

Please refer disclaimer at https://geplcapital.com/term-disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here